Welcome to our dedicated page for Occidental Pet SEC filings (Ticker: OXY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Occidental Petroleum Corporation (NYSE: OXY) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Occidental is an international energy company focused on producing, marketing and transporting oil and natural gas, with assets primarily in the United States, the Middle East and North Africa, and it uses SEC filings to report material events, financial results and capital markets activities.
Occidental regularly files Current Reports on Form 8-K to disclose significant developments. In the supplied materials, these include filings announcing quarterly financial condition and results of operations, earnings considerations that management believes will impact upcoming results, and other events such as securities offerings related to outstanding publicly traded warrants. The company also files Form 8-K reports to describe major transactions, such as the acquisition of CrownRock, L.P. and the divestiture of its chemical business, OxyChem, to Berkshire Hathaway Inc., including key terms and references to related pro forma financial information.
One Form 8-K dated October 3, 2025 describes the purchase and sale agreement under which Berkshire Hathaway agreed to acquire all of the issued and outstanding equity interests in Occidental Chemical Corporation, which held Occidental’s chemical business. A subsequent Form 8-K dated January 2, 2026 reports completion of this divestiture for $9.7 billion in cash, subject to customary purchase price adjustments, and includes references to unaudited pro forma condensed consolidated financial statements giving effect to the transaction and certain debt redemption activities.
Other filings referenced in the provided data include Form 8-K reports furnishing updated pro forma financial information related to the CrownRock acquisition, as well as filings that attach investor presentations or joint press releases about significant transactions. Through these filings, investors can review how Occidental presents its financial position, portfolio changes, risk factors and forward-looking statements in an official regulatory context.
On Stock Titan, these SEC filings are paired with AI-powered summaries designed to explain the key points of lengthy documents, such as Form 8-K exhibits, annual reports on Form 10-K or quarterly reports on Form 10-Q. Users can quickly see the main implications of new filings, track items like material acquisitions and divestitures, and review disclosures related to reserves, debt management and other factors that Occidental identifies as important in its cautionary statements.
Occidental Corporation has agreed to sell its chemical business, Occidental Chemical Corporation (OxyChem), to Berkshire Hathaway Inc. in an all-cash transaction valued at $9.7 billion, subject to customary adjustments for cash, debt and working capital. OxyChem is a global producer of commodity chemicals used in water treatment, pharmaceuticals, healthcare, and construction-related markets.
The deal is being executed through subsidiaries Occidental Chemical Holding, LLC and Environmental Resource Holdings, LLC, and will close after required regulatory approvals, including expiration of the Hart-Scott-Rodino waiting period, and other customary conditions are met. Either party may terminate the agreement if closing has not occurred by March 30, 2026, with an automatic 90‑day extension if certain regulatory conditions remain outstanding.
Occidental will provide various indemnities to Berkshire Hathaway for specified pre‑closing liabilities, including certain tax and environmental matters, while a separate subsidiary will retain legacy environmental liabilities at OxyChem’s legacy sites and manage related remediation under a dedicated agreement.
Occidental Petroleum Corporation has agreed to sell all of the issued and outstanding equity interests of Occidental Chemical Corporation, which holds its chemical business, to Berkshire Hathaway Inc. in an all-cash transaction valued at $9.7 billion, subject to customary purchase price adjustments. The parties announced they have signed a definitive agreement, and Occidental released an investor presentation and joint press release describing the transaction and its anticipated benefits and risks.
Warren E. Buffett, Berkshire Hathaway and National Indemnity report a 32.7% economic interest in Occidental Petroleum (OXY). The filing shows each Reporting Person beneficially owns 348,853,373.38 shares of Occidental common stock, calculated to include warrants exercisable into an aggregate of 83,911,942.38 shares. The Berkshire warrants were originally issued in 2019 and adjusted multiple times: the exercise price lowered to $59.624 per share in 2020 and further adjusted to $59.586 per share with an increase to 83,911,942.38 underlying shares as of July 17, 2025. The filing reports no sole voting or dispositive power and lists only shared voting and dispositive power for the reported holdings.